http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07e368499513bd026f21dccad3559eb7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Massuti |
| name | Bartomeu Massuti |
| given-name | Bartomeu |
| organization-name | Medical Oncology Department, University General Hospital of Alicante, Alicante, Spain Fundación ECO (Excelencia y Calidad en Oncología), Madrid, Spain; Servicio de Oncología Médica, Hospital General Universitario de Alicante, Alicante, Spain Medical Oncology Department, Hospital General Universitario Alicante, Alicante, Spain. 7Hospital General de Alicante, Alicante, Spain; Medical Oncology Service, Hospital General de Alicante, Alicante, Spain. Medical Oncology Department Hospital General Universitario de Alicante Alicante Spain Hospital General de Alicante, Alicante, Spain From the Hospital Ramon y Cajal; Hospital San Carlos; Clinica Puerta de Hierro; Fundacion Jimenez Diaz; Autonomous University of Madrid, Madrid; Hospital Clinico, Valencia; Hospital Clinico; Hospital Miguel Servet, Zaragoza; Hospital Germans Trias i Pujol, Catalan Institute of Oncology, Badalona; Hospital Duran i Reynals, Catalan Institute of Oncology, Bellvitge; Hospital Cruces, Bilbao; and Hospital General, Alicante, Spain Hospital General de Alicante, Alicante, Spain ; 6Hospital General de Alicante, Alicante, Spain Hospital General de Alicante, Alicante, Spain. Authors' Affiliations: 1Pangaea Biotech, Barcelona, Spain; 2Hospital Sant Pau, Barcelona, Spain; 3Hospital Vall d'Hebron, Barcelona, Spain; 4Molecular Oncology Research (MORe) Foundation, Barcelona, Spain; 5Pivotal, Madrid; 6Hospital General de Alicante, Alicante, Spain; 7Catalan Institute of Oncology, Badalona, Barcelona, Spain; 8Complejo Hospitalario Universitario, La Coruña, Spain; 9Centre François Baclesse, Caen, France; 10Drum Tower Hospital, Nanjing, China; 11Kyushu University, Fukuoka, Japan; 12Cancer Therapeutics Innovation Group, New York, New York, USA; and 13Helen Diller Comprehensive Cancer Center, University of California, San Francisco, California, USA From Hospital Universitario Puerta de Hierro–Majadahonda (M.P., V.C., R.S.-B., J.M.-L., A.C.-B., A.R.), Hospital Universitario Clínico San Carlos (J.L.G.-L., C.A.R., F.H.-T.), Hospital Universitario 12 de Octubre (S.P.), Hospital Universitario La Paz (J.C.), and the Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (R. Benítez), Madrid, Institut Català d’Oncologia, L’Hospitalet de Llobregat (E.N., R.P.), Vall d’Hebron Institute of Oncology, Hospital Universitari Vall... Alicante University Hospital, Alicante, Spain f Medical Oncology Department, Hospital Universitario de Alicante, Alicante, Spain; Medical Oncology Department, Hospital Universitario de Alicante, Alicante, Spain 18Hospital General de Alicante, Alicante, Spain. Alicante University Hospital, Alicante, Spain. e Hospital General de Alicante, Alicante, Spain; Hospital General de Alicante, Spain ; 10Department of Medical Oncology, Hospital General Universitario, Alicante, Spain. Medical Oncology Department, Hospital General Universitario de Elche, Alicante, Spain From the Hospital Carlos Haya, Malaga; Hospital Lozano Blesa, Zaragoza; Hospital General de Alicante, Alicante; Catalan Institute of Oncology, Hospital Duran i Reynals; Hospital Clinic; Hospital Vall d'Hebron, Barcelona; Hospital Alcorcon; Hospital Puerta de Hierro; Hospital Doce de Octubre; Fundacion Jimenez Diaz’ Autonomous University of Madrid, Madrid; Hospital de Cruces, Barakaldo-Bizkaia; Valencia Institute of Oncology; Hospital Arnau de Vilanova; Hospital General de Valencia, Valencia; Catalan... Authors' Affiliations: 1Catalan Institute of Oncology, Hospital Germans Trias i Pujol; 2Hospital Germans Trias i Pujol, Badalona, Spain; 3USP Dexeus University Institute, Pangaea Biotech; 4Hospital Clinic; and 5Hospital Sant Pau, Barcelona, Spain; 6Catalan Institute of Oncology, Hospital Duran i Reynals, Bellvitge, Spain; 7Hospital Lozano Blesa, Zaragoza, Spain; 8Hospital Puerta de Hierro; 9MD Anderson; and 10Autonomous University of Madrid, Madrid, Spain; 11Hospital Carlos Haya, Malaga, Spain; 12Hospital Clinico Universitario, Valencia, Spain; 13Hospital Juan Canalejo, La Coruña, Spain; 14Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain; 15Hospital General, Alicante, Spain; 16University of Alcala de Henares, Alcala de Henares, Spain; 17Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York; and 18Howard Hughes Medical Institute, Chevy Chase, Maryland Romain Corre and Hervé Léna, Centre Hospitalier Universitaire de Rennes, Rennes; Laurent Greillier, Université de Médecine, Marseille; Hervé Le Caër, Centre Hospitalier de Draguignan, Draguignan; Clarisse Audigier-Valette, Centre Hospitalier Intercommunal de Toulon; Henri Bérard, Hôpital Inter Armées Sainte-Anne, Toulon; Nathalie Baize, Centre Hospitalier Universitaire d’Angers, Angers; Lionel Falchero, Centre Hospitalier de Villefranche sur Saône, Villefranche sur Saône; Isabelle Monnet and Christos... Alicante General Hospital, Pintor Baeza, 11, ES-03010 Alicante, Spain. From the Hospital Duran i Reynals, Barcelona; Hospital Germans Trias i Pujol, Badalona; Hospital Miguel Servet, Zaragoza; Hospital Arnau de Vilanova, Valencia; Hospital General de Alicante, Alicante; Hospital General de Elche, Elche; Hospital Universitario Reina Sofia, Cordoba; Hospital Infanta Cristina, Badajoz; Hospital 12 de Octubre, Madrid; Hospital La Fe, Valencia; Hospital del Mar, Barcelona; Hospital Clínico, Madrid, Spain; and Lilly Research Laboratories, Indianapolis, IN. |
Incoming Links
Total number of triples: 109.